Dimension Therapeutics Profile

5.98
USD 0.01  0.17%
5.9Last Month High 6.0 
5.95Trading Day  High 6.0 

Acquisition by Annalisa Jenkins of 150000 shares of Dimension Therapeutics subject to Rule 16b-3

Dimension Therapeutics Inc insider trading alert for grant of stock option (right to buy) by Annalisa Jenkins, President and CEO, on July 5, 2017. This event was filed by Dimension Therapeutics In with SEC on 2017-07-05. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Dimension Therapeutics Summary

Dimension Therapeutics Inc (DMTX) is traded on NASDAQ in USA. It is located in MASSACHUSETTS, U.S.A and employs 53 people. Dimension Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 150.6 M. Dimension Therapeutics Inc has 25.21 M outstanding shares of which 167.31 K shares are currently shorted by private and institutional investors with about 4.13 trading days to cover. Dimension Therapeutics currently holds about 47.49 M in cash with (55.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.9.
Check Dimension Therapeutics Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Orbimed Advisors LlcCommon Shares5.4 M7.8 M
Fmr LlcCommon Shares4.9 M7.1 M
View Dimension Therapeutics Diagnostics

Selected Dimension Therapeutics Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Dimension Therapeutics Against Markets

Current Ratings  

Dimension Therapeutics 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
10 
Chance of
< 2% 
Dimension Therapeutics, Inc., a gene therapy platform company, focuses on discovering and developing therapeutic solutions for people living with rare diseases associated with the liver and caused by genetic mutations. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameDimension Therapeutics Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationMASSACHUSETTS, U.S.A
Business AddressDimension Therapeutics, Inc.Cambridge, MA
ExchangeNASDAQ
CIK Number01592288.0
CUSIP25433V105
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.dimensiontx.com
Contact Number617 401 0011
CurrencyUSD - US Dollar

Did you try this?

Run Insider Screener Now
   

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
Hide  View All  Next  Launch Insider Screener

Recommendations

Dimension Therapeutics Analyst Recommendations
Target PriceAdvice# of Analysts
16.33Buy3Odds
Dimension Therapeutics Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Dimension Therapeutics Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Dimension Therapeutics Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.54March 23, 2017
Dimension Therapeutics Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate